The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Considering shares in issue are about to double, the company haven't provided any tangible evidence they have capacity to generate meaningful revenue and will likely burn through the recently raised funds in 9 months, I'd say the current share price is pretty generous!
An honest account?
He's already lost all credibility. His level of ignorance is remarkable to do a ramping interview to reassure shareholders of a bright and transparent future all whilst in the knowledge of a shambolic fundraise a week later!?
Any sense in this directorial handover would've either been done post-raise announcement to legitimately justify a fresh start or at the very least not made any public announcements about future until the full situational truth was available.
He was handed a pile of S**t but he made the decision to clap.
Anyone thinking they have nothing to lose from here is sadly mistaken.
Do we have viridian to thank for their masterful input in this internal promotion of our new & utterly under-qualified and inexperienced new CEO? Or have they now given up trying and was their last input in convincing Michael Sandore to join (by feeding him the same tripe that's been fed to shareholders for over a year) before he took a look beneath the surface and ran a mile.
Amazed by the price action here on what is a car crash of an update. Would not be surprised if they now use this management re-jig as a futile attempt to pass off any imminent cash raise as a 'new dawn'.
I doubt its free. There must be some commercial aspect to it for Metro - but good exposure nevertheless.
'In future, the Group will not issue sales updates on a regular quarterly basis and will instead seek to communicate more fluidly with the market as new information becomes available. In the meantime, the Board is working closely with the Group's strategic advisors, Viridian Capital Advisors, to develop and deploy more effective market communication strategies.'
Approaching four months since this update and their commitment to more effective market communication. Am I being impatient or is it fair to have expected more at this point? No updates on sales, no roll out progress, new products (pouches, tinctures, gummies) but no insight on sales strategy for these products (other than website).
So the newly appointed CCO fancied committing career suicide and jumping on a sinking ship? Don't think so.
Disinterest until hard and fast data is released with regards to roll out success and sell through rates would be my guess.
I am disappointed that operational news flow with regards to sales/roll out hasn't been more forthcoming since Viridian came on board.
Thank you.
Is an exciting move. I will be looking forward to seeing how they approach the product packaging and branding. Whether looking to continue/piggy back on the existing CHILL CBD branding or something completely new.
'Chill joins short list of brands licensed to use TFN® from market leader, Next Generation Labs'
Anyone know which other brands are on this short list?
End of august for year results to March 21 (which the sooner we can be done with the better)
Quarterly updates on sales should be due in October.
The BOD set out intention to report sales quarterly from July onwards and the most sensible move is to stick to that and not blurt out a panicked update of a new order here and a new order there.
Ahh the hypocrisy when your last message on another board reads; 'Way under valued. My average is high 50s but i know this will be much higher short term. Buyers at this price can easily double their money in the coming months.'
We have the brand, we have the product and we have the distribution. Traction will come and when it does, it comes fast. Chill.